Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer M. VenturiniL. Del MastroRiccardo Rosso ORIGINAL ARTICLE Pages: 487 - 494
Inhibitory effect of a spicamycin derivative, KRN5500, on the growth of hepatic metastasis of human colon cancer-producing tissue polypeptide antigen M. KamishoharaHiroyuki KawaiNoboru Otake ORIGINAL ARTICLE Pages: 495 - 498
In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-Bearing rats Damayanthi DevineniAndres Klein-SzantoJ. M. Gallo ORIGINAL ARTICLE Pages: 499 - 507
Advantages and safety of local treatment with MMC/Beriplast P for cancer tumors Hideo MatsuokaK. YanoHirotsugu Tomoda ORIGINAL ARTICLE Pages: 508 - 512
In vivo antitumor activity of S 16020-2, a new olivacine derivative N. GuilbaudL. Kraus-BerthierG. Atassi ORIGINAL ARTICLE Pages: 513 - 521
Interferon augments the cytotoxicity of hydroxyurea without enhancing its activity against the M2 subunit of ribonucleotide reductase: effects in wild-type and resistant human colon cancer cells S. WadlerRobert HorowitzEdward L. Schwartz ORIGINAL ARTICLE Pages: 522 - 528
Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks Scott WadlerRobert HorowitzEdward L. Schwartz ORIGINAL ARTICLE Pages: 529 - 535
A limited sampling strategy for estimation of the cladribine plasma area under the concentration versus time curve after intermittent i.v. infusion, s.c. injection, and oral administration J. LiliemarkFreidoun AlbertioniStaffan Eksborg ORIGINAL ARTICLE Pages: 536 - 540
Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative O. PaganiM. ZucchettiF. Cavalli ORIGINAL ARTICLE Pages: 541 - 547
A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines A. R. CattanZ. T. Maung ORIGINAL ARTICLE Pages: 548 - 552
Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide±hepatic enzyme effectors B. A. TeicherSylvia A. HoldenLois J. Ayash ORIGINAL ARTICLE Pages: 553 - 560
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer Giorgio Vittorio ScagliottiUmberto RicardiMaurizio Tonato CLINICAL TRIAL REPORT Pages: 561 - 565
Methotrexate removal during haemodialysis in a patient with advanced laryngeal carcinoma A. H. ThomsonMargaret DalyPaul Symonds SHORT COMMUNICATION Pages: 566 - 570
Comparative serum protein binding of anthracycline derivatives Olivier ChassanySaïk UrienJean-Paul Tillement SHORT COMMUNICATION Pages: 571 - 573
Venous thrombosis as a complication of antiemetic treatment P. H. T. J. SleeC. J. Rodenburg LETTER TO THE EDITORS Pages: 574 - 574
